ACRO Biomedical Co., Ltd. (TPEX:6748)
Taiwan
· Delayed Price · Currency is TWD 58.70
-2.60 (-4.24%)
Mar 9, 2026, 1:45 PM CST
ACRO Biomedical Market Cap
ACRO Biomedical has a market cap or net worth of 3.80 billion as of March 9, 2026. Its market cap has increased by 158.75% in one year.
Market Cap
3.80B
Enterprise Value
3.36B
Revenue
36.50M
Ranking
n/a
PE Ratio
n/a
Stock Price
58.70
Market Cap Chart
Since July 27, 2021, ACRO Biomedical's market cap has increased from 990.62M to 3.80B, an increase of 283.77%. That is a compound annual growth rate of 33.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 3.75B | -7.12% |
| Dec 31, 2025 | 4.04B | 158.32% |
| Dec 31, 2024 | 1.56B | -35.07% |
| Dec 29, 2023 | 2.41B | 135.16% |
| Dec 30, 2022 | 1.02B | 9.09% |
| Dec 30, 2021 | 938.97M | -5.21% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genovate Biotechnology | 3.70B |
| Sagittarius Life Science | 3.51B |
| Formosa Pharmaceuticals | 4.08B |
| BRIM Biotechnology | 3.44B |
| Intech Biopharm | 3.38B |
| Energenesis Biomedical CO.,LTD. | 4.18B |
| Medigen Biotechnology | 4.20B |
| Shine-On BioMedical | 3.30B |